Crystal Form I Purity via Isopropyl Alcohol Crystallization

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for preparing 4-hydroxy-2-oxo-1-pyrrolidine acetamide result in products with low purity and high impurity content, which affects their therapeutic efficacy and industrial scalability.

Innovation Solution

A method involving dissolving crude racemate in isopropyl alcohol to achieve supersaturation, followed by heating and stirring at 38-42°C for 7 hours, filtering, and drying under vacuum to obtain crystal form I with high purity, characterized by specific diffraction peaks and infrared absorption peaks, achieving a purity of up to 99.5% and a yield of 90%.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If conventional preparation methods are used to synthesize 4-hydroxy-2-oxo-1-pyrrolidine acetamide, then the synthesis process is relatively simple, but the product purity is low and impurity content is high

Engineering Contradiction:
Improveproduct purityVSAvoidprocess complexity
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The preparation process is divided into distinct stages: initial synthesis to obtain crude product, followed by separate purification steps including dissolution in isopropyl alcohol, heating at 38-42°C for 7 hours, filtration, and drying. This segmentation allows each stage to be optimized independently, achieving 99.5% purity without excessive overall complexity

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

Isopropyl alcohol is introduced as an intermediary solvent to facilitate purification. The crude racemate dissolves in isopropyl alcohol under controlled heating, allowing impurities to be separated during filtration. This intermediary substance enables high purity recovery while maintaining process simplicity

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If conventional preparation methods are used, then the process is straightforward, but the therapeutic efficacy is reduced due to low purity

Engineering Contradiction:
Improvetherapeutic efficacyVSAvoidmanufacturing ease
Core Design Contradiction:
ReliabilityVSEase of manufacture

Solution Approach 1:

Specific parameters are optimized to balance efficacy and manufacturability: temperature controlled at 38-42°C for 7 hours during heating, using isopropyl alcohol as solvent, and vacuum drying for 24 hours. These parameter changes ensure 99.5% purity for reliable therapeutic efficacy while maintaining straightforward manufacturing procedures

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The purification process is designed to be self-correcting: the controlled heating and stirring conditions automatically promote crystal formation of the pure racemate, which then self-separates during filtration. This self-service mechanism ensures high purity without requiring complex monitoring or intervention, maintaining manufacturing ease

Inventive Principle:
Principle #25Self-service

3Manufacturing precision

If high purity crystal form I is obtained through extended heating and stirring, then purity reaches 99.5%, but production time increases to 7 hours

Engineering Contradiction:
ImprovepurityVSAvoidproduction time
Core Design Contradiction:
Manufacturing precisionVSProductivity

Solution Approach 1:

The temperature is precisely controlled within 38-42°C during the 7-hour heating period, and vacuum drying is applied for 24 hours. These parameter optimizations ensure that the purification reaches 99.5% purity efficiently, minimizing the time required while achieving the desired purity level

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The heating and stirring process continues uninterrupted for 7 hours to ensure complete purification and crystal formation. This continuous useful action maximizes purity achievement within the minimum necessary time, avoiding repeated cycles that would extend total production time

Inventive Principle:
Principle #20Continuity of useful action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The method produces crystal form I of 4-hydroxy-2-oxo-1-pyrrolidine acetamide with high purity and desirable yield, suitable for large-scale industrial production and effective in treating cerebral and cognitive disorders, with simple and cost-effective control conditions.

Implementation Method 1

dissolving crude racemate of 4-hydroxy-2-oxo-1-pyrrolidine acetamide in isopropyl alcohol to reach supersaturation

Methodology Applied
Scientific EffectDissolution: Solvation

Implementation Method 2

heating and stirring for 7h at 38-42 °C to obtain a suspended sediment

Methodology Applied
Scientific EffectCrystallization: Crystallisation

Implementation Method 3

dissolving crude racemate of 4-hydroxy-2-oxo-1-pyrrolidine acetamide in isopropyl alcohol to reach supersaturation

Methodology Applied
Scientific EffectSupersaturation: Supersaturation

Implementation Method 4

drying under vacuum for 24h to obtain crystalline powder

Methodology Applied
Scientific EffectEvaporation: Evaporation

Implementation Method 5

drying under vacuum for 24h to obtain crystalline powder

Methodology Applied
Scientific EffectVacuum: Vacuum

Data Source

PatentEP2743261B1Preparation method of crystal form i of the racemate of 4-hydroxy-2-oxo-1-pyrrolidine-acetamide
Publication Date: 2017.11.29 CHONGQING RUNZE PHARM CO LTD
  • EP2743261B1 patent drawingFigure 1~2
  • EP2743261B1 patent drawingFigure 3~4
  • EP2743261B1 patent drawingFigure 5

AI summary

A crystal form I of the racemate of 4-hydroxy-2-oxo-1-pyrrolidine acetamide is prepared by the following steps: dissolving crude racemate of 4-hydroxy-2-oxo-1-pyrrolidine acetamide in a small molecular alcohol solvent to reach supersaturation; heating and stirring overnight at 38-42°C to obtain an suspended sediment; filtering and drying to obtain a crystal. The crystal form I of the racemate of 4-hydroxy-2-oxo-1-pyrrolidine acetamide in the present invention has a high purity which can reach 99.5%.